Literature DB >> 33658323

Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

Mohamed Attauabi1,2,3, Jakob Seidelin3, Johan Burisch4,2.   

Abstract

Entities:  

Keywords:  5-aminosalicylic acid (5-ASA); COVID-19; crohn's disease; inflammatory bowel disease; ulcerative colitis

Year:  2021        PMID： 33658323     DOI： 10.1136/gutjnl-2021-324397

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study.

Authors:  Jin Wook Lee; Eun Mi Song; Sung-Ae Jung; Sung Hoon Jung; Kwang Woo Kim; Seong-Joon Koh; Hyun Jung Lee; Seung Wook Hong; Jin Hwa Park; Sung Wook Hwang; Dong-Hoon Yang; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Sang Hyoung Park
Journal:  J Korean Med Sci       Date:  2021-12-13       Impact factor: 2.153

Review 2.  SARS-CoV-2 vaccination in patients with inflammatory bowel disease.

Authors:  Ralley E Prentice; Clarissa Rentsch; Aysha H Al-Ani; Eva Zhang; Douglas Johnson; John Halliday; Robert Bryant; Jacob Begun; Mark G Ward; Peter J Lewindon; Susan J Connor; Simon Ghaly; Britt Christensen
Journal:  GastroHep       Date:  2021-07-23

3.  The impact of COVID-19 on patients with IBD in a prospective European cohort study.

Authors:  Aurelien Amiot; Jean-Francois Rahier; Filip Baert; Stephane Nahon; Ailsa Hart; Nikos Viazis; Livia Biancone; Eugeni Domenech; Catherine Reenears; Laurent Peyrin-Biroulet; Laurent Beaugerie; Johan Burisch
Journal:  J Crohns Colitis       Date:  2022-06-29       Impact factor: 10.020

Review 4.  Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives.

Authors:  Carles Suria; Marta M Bosca-Watts; Pablo Navarro; Joan Tosca; Rosario Anton; Ana Sanahuja; Marta Revaliente; Miguel Minguez
Journal:  Gastroenterol Hepatol       Date:  2021-06-23       Impact factor: 5.867

Review 5.  Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment.

Authors:  Naser-Aldin Lashgari; Nazanin Momeni Roudsari; Saeideh Momtaz; Amir Hossein Abdolghaffari
Journal:  World J Gastroenterol       Date:  2021-12-14       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.